We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+15.81%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$19.6B
AUM Growth
+$879M
(+4.7%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-6.05%
Top 10 Holdings %
Top 10 Hldgs %
34.09%
Holding
589
New
74
Increased
137
Reduced
233
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$96.2M |
| 2 |
DraftKings
DKNG
|
+$81.7M |
| 3 |
GE HealthCare
GEHC
|
+$81.1M |
| 4 |
GFL Environmental
GFL
|
+$77M |
| 5 |
Vaxcyte
PCVX
|
+$72.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$187M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$143M |
| 3 |
AbbVie
ABBV
|
+$112M |
| 4 |
Walt Disney
DIS
|
+$99.6M |
| 5 |
HSKA
Heska Corp
HSKA
|
+$80.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.16% |
| 2 | Healthcare | 20.31% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Industrials | 10.17% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Salesforce
CRM
$141B
| $51.6M | 0.26% |
244,062
-53,383
| -18% | -$10.9M |
|
102
GitLab
GTLB
$5.5B
| $51.2M | 0.26% |
1,002,326
+491,169
| +96% | +$18.3M |
|
|
AXON
103
Axon Enterprise
AXON
$41.9B
| $50.9M | 0.26% |
260,867
+52,638
| +25% | +$10.9M |
|
|
AGTI
104
DELISTED
Agiliti Inc
AGTI
| $46.5M | 0.24% |
2,816,724
-155,986
| -5% | -$2.61M |
|
105
BioLife Solutions
BLFS
$1.46B
| $45.8M | 0.23% |
2,073,114
+147,899
| +8% | +$3.12M |
|
106
Vertiv
VRT
$107B
| $45.7M | 0.23% |
1,844,069
+1,585,767
| +614% | +$27.2M |
|
|
EVBG
107
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $45M | 0.23% |
1,672,635
-449,563
| -21% | -$12.1M |
|
108
Progressive
PGR
$125B
| $44M | 0.22% |
332,211
-166,378
| -33% | -$22.3M |
|
109
Quanta Services
PWR
$92.1B
| $43.3M | 0.22% |
220,665
+218,906
| +12,445% | +$38.2M |
|
110
Tenable Holdings
TENB
$3.61B
| $42.9M | 0.22% |
984,971
+113,025
| +13% | +$4.62M |
|
111
Ollie's Bargain Outlet
OLLI
$4.06B
| $42M | 0.21% |
724,334
+172,565
| +31% | +$10.6M |
|
|
RETA
112
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $41.5M | 0.21% |
407,170
+232,469
| +133% | +$22M |
|
113
CryoPort
CYRX
$760M
| $41.4M | 0.21% |
2,398,364
-16,286
| -0.7% | -$333K |
|
|
SILK
114
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $40.3M | 0.21% |
1,241,469
+218,927
| +21% | +$7.99M |
|
115
Viper Energy
VNOM
$8.49B
| $39.5M | 0.2% |
1,473,972
-340,355
| -19% | -$9.32M |
|
|
ALTR
116
DELISTED
Altair Engineering Inc
ALTR
| $39.2M | 0.2% |
516,329
+165,984
| +47% | +$11.9M |
|
117
Manhattan Associates
MANH
$9.45B
| $38.8M | 0.2% |
194,307
+20,693
| +12% | +$3.59M |
|
118
Kura Sushi USA
KRUS
$562M
| $38.3M | 0.2% |
411,712
+284,803
| +224% | +$21M |
|
119
MoonLake Immunotherapeutics
MLTX
$1.66B
| $38.1M | 0.19% |
747,605
+640,685
| +599% | +$17.2M |
|
120
nCino
NCNO
$1.95B
| $37.9M | 0.19% |
1,258,494
+1,208,494
| +2,417% | +$30.8M |
|
121
Waste Management
WM
$96.2B
| $37.7M | 0.19% |
217,188
+140,465
| +183% | +$23.2M |
|
122
Rapid7
RPD
$648M
| $37.6M | 0.19% |
830,616
-39,920
| -5% | -$1.85M |
|
|
SMAR
123
DELISTED
Smartsheet Inc.
SMAR
| $37.5M | 0.19% |
981,263
+87,343
| +10% | +$3.78M |
|
124
West Pharmaceutical
WST
$23.5B
| $37.5M | 0.19% |
98,040
+28,884
| +42% | +$10.3M |
|
125
Xometry
XMTR
$4.76B
| $37.1M | 0.19% |
1,752,908
-287,892
| -14% | -$5.03M |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q2 2023 Portfolio in Review
As of Q2 2023, Fred Alger Management held 589 positions worth $19.6B, up 4.7% from $18.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Fred Alger Management withdrew a net $1.18B in Q2 2023, closing 78 positions and reducing 233 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $143M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in DraftKings worth $94.2M.
- Fred Alger Management's largest Q2 2023 buy was DraftKings: 3,544,411 shares worth $94.2M.
- Fred Alger Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $96.2M increase.
- Fred Alger Management's biggest Q2 2023 reduction was Intuit, cutting an estimated $187M.
- Fred Alger Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $143M.
- Fred Alger Management's ten largest holdings make up 34% of its $19.6B portfolio in Q2 2023.
- Fred Alger Management opened 74 new positions and closed 78 in Q2 2023.
- Fred Alger Management's portfolio value rose 4.7% quarter-over-quarter to $19.6B.
Based on Fred Alger Management's 13F filing for Q2 2023, filed 14 Aug 2023.